Gemcitabine and liposomal doxorubicin in biliary and hepatic carcinoma (HCC) chemotherapy: preliminary results and review of the literature

Gemcitabine and liposomal doxorubicin in biliary and hepatic carcinoma (HCC) chemotherapy: preliminary results and review of the literature D. Pastorelli*, G. Cartei, F. Zustovich, F. Marchese, G. Artioli, S. Zovato, S. Binato, R. Ceravolo, S. Cingarlini, F. Salmaso, M. Mattiazzi, C. Sanavio, F. Farinati, G. Zanus & U. Cillo O.U.C. Medical Oncology, Busonera Hospital 1 floor, National Oncology Institute of Veneto, IOV IRCCS, Padua; O.U. Epatobiliary Surgery and Hepatic Transplantation, Padua; Department of Gastroenterologic and Surgery Sciences ‘‘P.G. Cevese’’, Padua; Department of Medicine, General Hospital, Chioggia, Venice, Italy